Articles

Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or naturalkiller/T-cell lymphoma

Division of Medical Oncology, National Cancer Centre Singapore
Division of Medicine, Weill Cornell Medical College, New York
Division of Medical Oncology, National Cancer Centre Singapore
Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore
Division of Medical Oncology, National Cancer Centre Singapore
Division of Medical Oncology, National Cancer Centre Singapore
Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore
Division of Clinical Trials and Epidemiology, National Cancer Centre Singapore
Department of Nuclear Medicine and Molecular Imaging, Singapore General Hospital
Division of Medical Oncology, National Cancer Centre Singapore
Division of Medical Oncology, National Cancer Centre Singapore
Division of Medical Oncology, National Cancer Centre Singapore
Haematologica Early view Nov 5, 2020 https://doi.org/10.3324/haematol.2020.251454